A serological assay to detect SARS-CoV-2 seroconversion in humans

Journal: Nature Medicine

Published: 2020-05-12

DOI: 10.1038/s41591-020-0913-5

Affiliations: 21

Authors: 30

Go to article
Institutions Share
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.76
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia 0.07
University of Helsinki, Finland 0.04
University of California, Irvine (UCI), United States of America (USA) 0.03
University of Natural Resources and Life Sciences, Vienna (BOKU), Austria 0.02
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.02
Monash University, Australia 0.02
Alfred Health, Australia 0.02
University of Zurich (UZH), Switzerland 0.02
Helsinki University Central Hospital (HUCH), Finland 0.01
Mount Sinai Queens, MSHS, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER